Adaptimmune Therapeutics(DE:473A)
€0.010.00 (0.00%)
DE:473A
Adaptimmune Therapeutics Revenue
€0.01
At close:0.00 (0.00%)
Adaptimmune Therapeutics (473A) Revenue
0 Followers
Adaptimmune Therapeutics Revenue
Adaptimmune Therapeutics had a revenue of 13.68M in the quarter ending Jun 30, 2025, with 87.74%. This bring the company's revenue in the last twelve months to 65.08M, Decreased 63.77%. In the fiscal year ending Dec 31, 2024, Adaptimmune Therapeutics had annual revenue of 178.03M with 195.34% growth.
- Revenue (ttm)
- 65.08M
- Revenue Growth
- ―
- P/S Ratio
- 0.02
- Revenue/Employee
- EUR 654,529
- Employees
- 272
- Market Cap
- EUR 4.28M
Revenue Chart
Adaptimmune Therapeutics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 178.03M | 117.75M | 195.34% |
| Dec 31, 2023 | 60.28M | 33.13M | 122.05% |
| Dec 31, 2022 | 27.15M | 21.00M | 341.50% |
| Dec 31, 2021 | 6.15M | 2.19M | 55.36% |
| Dec 31, 2020 | 3.96M | 2.84M | 252.76% |
| Dec 31, 2019 | 1.12M | -58.38M | -98.11% |
| Dec 31, 2018 | 59.51M | 21.67M | 57.28% |
| Dec 31, 2017 | 37.83M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.